doi: 10.1097/CM9.0000000000001720.
Clinical prognosis of optimal medical therapy after percutaneous coronary intervention in patients with coronary heart disease
Affiliations
- PMID: 34387614
- PMCID: PMC8382476
- DOI: 10.1097/CM9.0000000000001720
Item in Clipboard
Clinical prognosis of optimal medical therapy after percutaneous coronary intervention in patients with coronary heart disease
Chin Med J (Engl).
.
No abstract available
Conflict of interest statement
None.
Similar articles
-
Prognostic Implications of Coronary Collaterals in Transmural Infarct-Related Percutaneous Coronary Interventions.Angiology. 2019 Mar;70(3):193-196. doi: 10.1177/0003319718775843. Epub 2018 May 10. Angiology. 2019. PMID: 29747518 No abstract available.
-
Optimal Treatment Strategies in Patients with Chronic Kidney Disease and Coronary Artery Disease.Am J Med. 2016 Dec;129(12):1288-1298. doi: 10.1016/j.amjmed.2016.06.046. Epub 2016 Jul 28. Am J Med. 2016. PMID: 27476086 Review.
-
[The Role of Percutaneous Coronary Revascularization in Chronic Coronary Syndromes].Praxis (Bern 1994). 2021 Apr;110(6):313-323. doi: 10.1024/1661-8157/a003648. Praxis (Bern 1994). 2021. PMID: 33906440 Review. German.
-
Coronary Artery Bypass Grafting Among Patients With Prior Percutaneous Coronary Interventions.J Am Heart Assoc. 2018 Oct 16;7(20):e010609. doi: 10.1161/JAHA.118.010609. J Am Heart Assoc. 2018. PMID: 30371281 Free PMC article.
-
[The application status of optimal medical therapy after percutaneous coronary intervention and its influence on prognosis].Zhonghua Yi Xue Za Zhi. 2021 Apr 20;101(15):1064-1070. doi: 10.3760/cma.j.cn112137-20200804-02280. Zhonghua Yi Xue Za Zhi. 2021. PMID: 33878833 Chinese.
Cited by
-
Optimal medical therapy, clinical outcome and its predictors in patients with acute coronary syndrome after discharge with secondary prevention medications at University of Gondar Comprehensive Specialized Hospital, North West Ethiopia, 2023: A retrospective follow-up study.BMC Cardiovasc Disord. 2024 Oct 3;24(1):533. doi: 10.1186/s12872-024-04199-x. BMC Cardiovasc Disord. 2024. PMID: 39363265 Free PMC article.
-
Residual coronary artery tree description and lesion EvaluaTion (CatLet) score, clinical variables, and their associations with outcome predictions in patients with acute myocardial infarction.Chin Med J (Engl). 2023 Oct 20;136(20):2459-2467. doi: 10.1097/CM9.0000000000002640. Epub 2023 Apr 12. Chin Med J (Engl). 2023. PMID: 37052135 Free PMC article.
References
-
- Pursnani S, Korley F, Gopaul R, Kanade P, Chandra N, Shaw RE, et al. . Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials. Circ Cardiovasc Interv 2012; 5:476–490. doi: 10.1161/CIRCINTERVENTIONS.112.970954. - PubMed
-
- Ardati AK, Pitt B, Smith DE, Aronow HD, Share D, Moscucci M, et al. . Current medical management of stable coronary artery disease before and after elective percutaneous coronary intervention. Am Heart J 2013; 165:778–784. doi: 10.1016/j.ahj.2013.01.015. - PubMed
-
- Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, et al. . Authors/Task Force Members. 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014; 35:2541–2619. doi: 10.1093/eurheartj/ehu278. - PubMed
-
- Flather MD, Yusuf S, Kober L, Pfeffer M, Hall A, Murray G, et al. . Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 2000; 355:1575–1581. doi: 10.1016/s0140-6736(00)02212-1. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
